Array
(
[id] => 1413765
[patent_doc_number] => 06521456
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Cellular transport system for the transfer of a nucleic acid through the nuclear envelope and methods thereof'
[patent_app_type] => B1
[patent_app_number] => 09/869875
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8282
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521456.pdf
[firstpage_image] =>[orig_patent_app_number] => 09869875
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/869875 | Cellular transport system for the transfer of a nucleic acid through the nuclear envelope and methods thereof | Jul 5, 2001 | Issued |
Array
(
[id] => 1589886
[patent_doc_number] => 06482936
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/835811
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22942
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482936.pdf
[firstpage_image] =>[orig_patent_app_number] => 09835811
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/835811 | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | Apr 16, 2001 | Issued |
Array
(
[id] => 6242343
[patent_doc_number] => 20020045253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'METHODS COMPRISING APOPTOSIS INHIBITORS FOR THE GENERATION OF TRANSGENIC PIGS'
[patent_app_type] => new
[patent_app_number] => 09/819964
[patent_app_country] => US
[patent_app_date] => 2001-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 77892
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045253.pdf
[firstpage_image] =>[orig_patent_app_number] => 09819964
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/819964 | Methods comprising apoptosis inhibitors for the generation of transgenic pigs | Mar 27, 2001 | Issued |
Array
(
[id] => 1418491
[patent_doc_number] => 06506600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-14
[patent_title] => 'Secreting products from skin by adeno-associated virus (AAV) gene transfer'
[patent_app_type] => B2
[patent_app_number] => 09/813937
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16036
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/506/06506600.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813937
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813937 | Secreting products from skin by adeno-associated virus (AAV) gene transfer | Mar 21, 2001 | Issued |